Goodnews: PLASMA Ginamit sa Dalawang Matanda Naka RECOVER sa Covid-19 sa South Korea.

Maraming mga gamot ang pinag-aaralan sa ngayon kung ito ba ay maging solusyon sa covid-19, tulad ng Avigan, mga gamot sa flu, at isa pang naging suggestion mula sa mga expert ay ang paggamit ng tinatawag na convalescent plasma.

Nitong Martes lang sa South Korea , ang dalawang matandang infected sa covid-19 ay napabalitang gumaling mula sa severe pneumonia pagkatapos gamutin gamit ang plasma mula sa mga survivors, sabi ng researchers nitong Martes, na mukhang nagbibigay pag-asa sa nagaganap na global pandemic.

Maraming Scientists ang nagpo-point sa potential benefits ng plasma-blood fluid-from recovered individuals na may na develop na anitbodies laban sa virus na siyang dumedepensa kapag umataki ito.

Ayon pa sa ulat ng ABS-CBN:

Plasma therapy could become “an alternative treatment for patients in critical condition who do not respond to antiviral drugs,” said Choi Jun-yong, a doctor and researcher at Severance Hospital in Seoul, where both patients were treated.

But large-scale clinical trials were needed to prove its effectiveness, he added.

One of the 2 patients was a 71-year-old man with no underlying conditions who only improved when treated with plasma from a recovered patient in his 20s, along with steroids.

He was initially given malaria drugs and a respirator for severe pneumonia.

The other patient, a 67-year-old female, also did not respond to initial treatments including malaria, HIV drugs, and oxygen therapy. She began to recover after receiving plasma therapy and steroids at the same time, researchers said.

Their findings were published in the peer-reviewed Journal of Korean Medicine.

Kwon Jun-wook, an official at Seoul’s Central Disease Control Headquarters, said plasma therapy was “important” when there was “currently no vaccine or treatment available” for the virus.

He called on experts to examine the 2 cases urgently.

Research on plasma and other therapies “will proceed quickly,” Kwon added.

Small studies on plasma have demonstrated its effectiveness in treating infectious diseases, including Ebola and SARS.

Trials started in France on Tuesday involving 60 patients in Paris hospitals, half of whom will receive plasma from recovered patients.

The US Food and Drug Administration authorized physicians to experiment with the strategy to fight the coronavirus, and tests are also being carried out in China.

South Korea endured one of the worst early outbreaks of the virus, but appears to have brought it under control thanks to its extensive “trace, test and treat” program.